BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 8363998)

  • 1. Tropisetron in the control of nausea and vomiting induced by combined cancer chemotherapy in children.
    Gershanovich M; Kolygin B; Pirgach N
    Ann Oncol; 1993; 4 Suppl 3():35-7. PubMed ID: 8363998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ondansetron and tropisetron in the control of nausea and vomiting in children receiving combined cancer chemotherapy.
    Stiakaki E; Savvas S; Lydaki E; Bolonaki I; Kouvidi E; Dimitriou H; Kambourakis A; Kalmanti M
    Pediatr Hematol Oncol; 1999; 16(2):101-8. PubMed ID: 10100270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tropisetron: an update of its use in the prevention of chemotherapy-induced nausea and vomiting.
    Simpson K; Spencer CM; McClellan KJ
    Drugs; 2000 Jun; 59(6):1297-315. PubMed ID: 10882164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience.
    Sorbe BG
    Semin Oncol; 1994 Oct; 21(5 Suppl 9):20-6. PubMed ID: 9113123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compassionate use of tropisetron in patients at high risk of severe emesis.
    Bleiberg H; Van Belle S; Paridaens R; De Wasch G; Dirix LY; Tjean M
    Ann Oncol; 1993; 4 Suppl 3():43-5. PubMed ID: 8364000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of emesis by tropisetron in children receiving combined chemotherapy with cisplatin.
    Berberoglu S
    Pediatr Hematol Oncol; 1995; 12(5):479-83. PubMed ID: 8519633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tropisetron in the prevention of nausea and vomiting in 131 children receiving cytotoxic chemotherapy.
    Benoit Y; Hulstaert F; Vermylen C; Sariban E; Hoyoux C; Uyttebroeck A; Otten J; Laureys G; De Kerpel I; Nortier D
    Med Pediatr Oncol; 1995 Dec; 25(6):457-62. PubMed ID: 7565308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of tropisetron (Navoban) in controlling emesis induced in children by anti-cancer therapy.
    Rosso P; Cordero di Montezemolo L; Vivenza C; Nasi C; Tonello M; Valle P; Madon E
    Tumori; 1994 Dec; 80(6):459-63. PubMed ID: 7900236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tropisetron in the prevention of chemotherapy-induced nausea and vomiting in patients responding poorly to previous conventional antiemetic therapy.
    Bruntsch U; Rüfenacht E; Parker I; Drechsler S; de Bruijn K
    Ann Oncol; 1993; 4 Suppl 3():25-9. PubMed ID: 8363995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tropisetron in the prevention of acute and delayed nausea and vomiting over six courses of emetogenic chemotherapy.
    Bleiberg H; Hulstaert F; Buyse M; De Keyser P
    Anticancer Drugs; 1998 Oct; 9(9):773-7. PubMed ID: 9840722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tropisetron (Navoban) in the control of nausea and vomiting induced by combined cancer chemotherapy in children.
    Ozkan A; Yildiz I; Yüksel L; Apak H; Celkan T
    Jpn J Clin Oncol; 1999 Feb; 29(2):92-5. PubMed ID: 10089950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tropisetron in the prevention of chemotherapy-induced nausea and vomiting: the Nordic experience.
    Sorbe B
    Ann Oncol; 1993; 4 Suppl 3():39-42. PubMed ID: 8363999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of chemotherapy-induced nausea and vomiting by tropisetron (Navoban) alone or in combination with other antiemetic agents.
    Bruntsch U; Drechsler S; Eggert J; Gosse H; Ukena D; Imhoff W; Faerber L
    Semin Oncol; 1994 Oct; 21(5 Suppl 9):7-11. PubMed ID: 9113120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A report comparing the use of tropisetron (Navoban), a 5-HT3 antagonist, with a standard antiemetic regimen of dexamethasone and metoclopramide in cisplatin-treated patients under conditions of severe emesis.
    Madej G; Krzakowski M; Pawinski A; Lasota W; Rogowski W; Skoneczna I
    Semin Oncol; 1994 Oct; 21(5 Suppl 9):3-6. PubMed ID: 9113119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of tropisetron and granisetron in the control of nausea and vomiting in children receiving combined cancer chemotherapy.
    Aksoylar S; Akman SA; Ozgenç F; Kansoy S
    Pediatr Hematol Oncol; 2001 Sep; 18(6):397-406. PubMed ID: 11554235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control of nausea and vomiting by Navoban (tropisetron) in 131 children receiving cytotoxic chemotherapy.
    Benoit Y; Hulstaert F; Vermylen C; Sariban E; Hoyoux C; Uyttebroeck A; Otten J; Laureys G; De Kerpel I; Nortier D
    Anticancer Drugs; 1995 Feb; 6 Suppl 1():9-14. PubMed ID: 7749170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current issues in the management of nausea and vomiting.
    Gralla RJ
    Ann Oncol; 1993; 4 Suppl 3():3-7. PubMed ID: 8363996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and tolerability of tropisetron and dexamethasone in the control of nausea and vomiting induced by cisplatin.
    Schmidt M; Sorbe B; Högberg T; Himmelmann A; Räisänen I; Stockmeyer M; de Bruijn KM
    Ann Oncol; 1993; 4 Suppl 3():31-4. PubMed ID: 8363997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective randomized comparison of tropisetron with and without dexamethasone against high-dose metoclopramide in prophylaxis of acute and delayed cisplatin-induced nausea and vomiting.
    Malik I; Moid I; Khan Z; Hussain M
    Am J Clin Oncol; 1999 Apr; 22(2):126-30. PubMed ID: 10199444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal combination therapy with tropisetron in 445 patients with incomplete control of chemotherapy-induced nausea and vomiting.
    Hulstaert F; Van Belle S; Bleiberg H; Canon JL; Dewitte M; Buyse M; De Keyser P; Westelinck KJ
    J Clin Oncol; 1994 Nov; 12(11):2439-46. PubMed ID: 7964961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.